Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations
Author:
Publisher
Elsevier BV
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference52 articles.
1. Vernakalant selectively prolongs atrial refractoriness with no effect on ventricular refractoriness or defibrillation threshold in pigs;Bechard;J Cardiovasc Pharmacol,2011
2. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?;Ehrlich;Curr Opin Cardiol,2009
3. Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent;Fedida;Expert Opin Investig Drugs,2007
4. The mechanism of atrial antiarrhythmic action of RSD1235;Fedida;J Cardiovasc Electrophysiol,2005
5. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations;Sicouri;Heart Rhythm,2008
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation;Medicine;2022-03-11
2. Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models;PLOS Computational Biology;2016-12-16
3. Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndrome;EP Europace;2016-10-04
4. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome;Journal of Cardiovascular Electrophysiology;2016-07-13
5. Sotalol;Cardiac Electrophysiology Clinics;2016-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3